Hepatitis Conferences | Gastro Conferences | Hepatitis Meetings | Hepatitis Conference 2019 | Liver Conferences 2019 | Hepatitis Congress | Gastro events | Events | USA | Europe | UK |Middle East | Asia Pacific | Japan | May

Theme: Advancements in the Arena of Hepatitis and Liver diseases: A Hope of Cure

Hepatitis Congress 2019

Hepatitis Congress 2019

Hepatitis Conferences invites all the participants from all over the world to attend “7^th World Congress on Hepatitis & Liver Diseases” during March 15-16, 2020 in Osaka, Japan. The Hepatitis conference will be organized around the theme “Advancements in the arena of Hepatitis and Liver Diseases: A Hope of Cure”

Viral hepatitis is an infection that causes liver inflammation and damage. Inflammation is swelling that occurs when tissues of the body become injured or infected. Inflammation can damage organs. Researchers have discovered several different viruses that cause hepatitis, including hepatitis A, B, C, D, and E.

Conferenceseries LLC ltd Organizes 1000+ Global Events inclusive of 300+ International Conferences, 500+ Workshops and 200+ Symposiums every year across USA- Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contain over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend?

With members from around the world focused on learning about Hepatitis and Liver Diseases; this is your best opportunity to reach the largest assemblage of participants from the Hepatology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Hepatitis and Liver Diseases, treatment and surgery involved are hallmarks of this Hepatitis conference.

Hepatitis Conference 2020 welcomes Medical Hepatologist specialists, gastroenterologists, pathologists, Liver oncologists, Surgeons, Research scholars, Industrial professionals and Student delegates from biomedical and healthcare sectors to be a part of it. This Hepatitis Conference aims to bring together academicians, doctors, researchers, and industry personnel to meet, discuss and share innovations, research, and ideas on liver treatments for a greater development and more effective treatments.

Target Audience:

Business Entrepreneurs Public
Health Professionals
Drug Manufacturing Companies
Radiation Therapist
Hepatology Societies
Clinical Researchers
Leading world Doctors
Surgical and Medical Hepatologist
Young Researchers
Students & Delegates
Toxicologist and Nutritionist

Conference Highlights:

Hepatitis and Research Advancements
Hepatitis: Screening and Testing Methods
Applications of Stem cells
Hepatotoxicity
Therapeutic Targets: (Viral Liver Infections)
Liver Injury and Immune Responses
Liver Resection and Clinical Trails
Paediatric Hepatology
Hepatocellular Carcinoma (HCC) and TACE
Hepatic Perfusion Technique
Liver Imaging Modalities
Herbal Medicines and Liver diseases
Hepatic-Encephalopathy
Hepatitis, Liver Diseases, and Pregnancy

Liver diseases conferences welcomes you to attend 7^th World Congress on Hepatitis and Liver Diseases to speak on a theme “Advancements in the Arena of Hepatitis and Liver Diseases: A hope of Cure” during May 15-16, 2019 Osaka, Japan. The Hepatitis Conference is going to cover all aspects of scientific and technical advancements in the field of medical science, environmental science, and pharmaceutical science.

Following are the sessions and tracks which are going to discuss at Hepatitis Congress 2019

Track 1: Hepatitis and Research Advancements

Hepatitis refers to an inflammatory condition of the liver. It’s commonly caused by a viral infection, but there are other possible causes of hepatitis. These include autoimmune hepatitis and hepatitis that occurs as a secondary result of medications, drugs, toxins, and alcohol. Autoimmune hepatitis is a disease that occurs when your body makes antibodies against your liver tissue.

Viral infections of the liver that are classified as hepatitis include hepatitis A, B, C, D, and E. A different virus is responsible for each type of virally transmitted hepatitis. Hepatitis A is always an acute, short-term disease, while hepatitis B, C, and D are most likely to become on-going and chronic. Hepatitis E is usually acute but can be particularly dangerous for pregnant women.

16th World Congress on Gastroenterology & Therapeutics | January 30-31, 2019 Bangkok, Thailand | 20th World Congress on Gastroenterology | March 04-05, 2019 Berlin, Germany | 21st World Congress on Advances in Gastroenterology and Hepatology | May 15-16, 2019 Mercure Melbourne Albert Park, Melbourne, Australia | Physicians Meet on Gastroenterology and Digestive Disorders Conference | August 19-20, 2019 Auckland, New Zealand | 18th International Conference on Gastroenterology and Digestive Disorders | September 16-17, 2019 Dubai, UAE | 15th Annual Congress on Gastroenterology & Hepatology | September 27-28, 2019 Hong Kong | 19th World Gastroenterologists Summit | October 14-15, 2019 Sydney, Australia | 19th International Conference on Gastroenterology and Hepatology | November 10-11, 2019 Abu Dhabi, UAE | 4th International conference on Digestive and Metabolic Diseases | October 21-22, 2019 Rome, Italy | World Summit on Liver Cirrhosis and Hepatitis | September 23-24, 2019 Tokyo, Japan | 7th International Conference on Hepatology | July 15-16, 2019 Sydney, Australia | World Liver Conference 2019 | June 17-18, 2019 Columbus, Ohio, U.S.A | 7th World Congress on Hepatitis & Liver Diseases | May 15-16, 2019 Osaka, Japan | International Metabolic Diseases and Liver Cancer Conference | May 27-28, 2019 Istanbul, Turkey | International conference on Liver and Hepatitis | April 24-25, 2019 Budapest, Hungary | World Congress on Pancreatic Cancer and Liver Diseases | January 30-31, 2019 | Radisson Hotel Narita | Tokyo, Japan

Related Associations:

USA and Canada: American Gastroenterological Association, Canadian Association of Gastroenterology, North Carolina Society of Gastroenterology, Canadian Society of Gastroenterology Nurses and Associates, Florida Gastroenterological Society, Ontario Association of Gastroenterology, Alabama Gastroenterological Society, Comparative Gastroenterology Society, American Neuro-gastroenterology and Motility Society.

European Union and UK: British Society of Gastroenterology, European Society of Gastroenterology and Endoscopy Nurses and Associates, European Society of Gastrointestinal Endoscopy, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Scottish Society of Gastroenterology, British Society of Pediatric Gastroenterology, Hepatology and Nutrition, European Society of Coloproctology, European Helicobacter and Microbiota Study Group, European Society of Neuro-gastroenterology and Motility, European Society for Diseases of the Esophagus, European Society of Comparative Gastroenterology, European Society for Primary Care Gastroenterology, Norwegian Gastroenterological Association

Asia-Pacific and Middle East: Gastroenterological Society of Australia, Gastroenterological Association of Thailand(GAT), Indian Society of Gastroenterology, Philippine Society of Gastroenterology, Society for Gastroenterology & Hepatology in Nigeria, Gastroenterological Society of Taiwan.

Track 2: Hepatitis: Screening and Testing Methods

The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of a counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, hemodialysis patients, hemophiliacs, and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

Related Associations:

Track 3: Applications of Stem Cells

Stem cells are biological cells found in all multicellular organisms that can divide (through mitotic cell division) and differentiate into a diverse range of specialized cell types and can self-renew to produce more stem cells. Stem cells can be taken from a variety of sources, including umbilical cord blood, bone marrow etc.

Stem cells provide new ways to treat chronic liver disease. To produce new hepatocytes in the laboratory embryonic stem cells or induced pluripotent stem cells might be used for those patients whose liver has lost the capacity to regenerate. Stem cells are used for transplantation purpose. Bone Marrow transplantation is very useful to treat disorders.

Related Associations:

Track 4: Hepatotoxicity

Hepatotoxicity implies chemical-driven liver damage. The Drug-Induced Liver Injury (DILI) is a cause of acute and chronic liver disease. The liver assumes a focal part in changing and clearing synthetic substances and is defenseless to the danger from these specialists. Certain restorative specialists, when taken in overdoses and here and there notwithstanding when presented inside helpful extents, may harm the organ. Other chemical agents, such as those used in laboratories and industries, natural chemicals (e.g., microcystins) and herbal remedies can also induce hepatotoxicity. Chemicals that cause liver injury are called hepatotoxicity.

Related Associations:

Track 5: Therapeutic Targets: (Viral Liver Infections)

The improvement of new treatments for liver infections stays testing because of various variables, not the minimum of which is the uncommon and patho-organically mysterious nature of the illness. Be that as it may, with on-going advances in the comprehension of potential unthinking underpinnings and parallel experiences, new potential targets, and novel remedial operators are being assessed; we trust these can possibly prompt the foundation of sheltered and compelling medicinal treatments and consequently better results in treating liver illnesses.

Related Associations:

Track 6: Liver Injury and Immune Responses

Hepatic irritation is a typical finding amid an assortment of liver sicknesses including drug-prompted liver poisonous quality. The provocative phenotype can be credited to the intrinsic safe reaction produced by Kupffer cells, monocytes, neutrophils, and lymphocytes. The versatile invulnerable framework is additionally affected by the intrinsic resistant reaction prompting liver harm.

Related Associations:

Track 7: Liver Resection and Clinical Trails

A liver resection is the surgical removal of all or a portion of the liver. It is also referred to as a hepatectomy, full or partial. A complete liver resection is performed in the setting of a transplant a diseased liver is removed from a deceased donor (cadaver). A living donor may also provide a piece of liver tissue which is procured through a partial hepatectomy. The procedure may be performed through a traditional open procedure or using minimally invasive techniques.

Related Associations:

Track 8: Paediatric Hepatology

Paediatric liver maladies are not extremely normal, and numerous paediatric residency programs don't have ensured hepatologists on the staff group, which may influence the solace level paediatricians to have with dealing with youngsters with liver illnesses. In the articles introduced here, we look to feature the changed liver infections that could be experienced in the general paediatric world, and also liver transplantation—when it turns into the main treatment alternative to fix the liver ailment.

Related Associations:

Track 9: Hepatocellular Carcinoma (HCC) and Transarterial ChemoEmbolization (TACE)

Hepatocellular carcinoma (HCC) is the most widely recognized kind of essential liver growth in grown-ups and is the most well-known reason for death in individuals with cirrhosis. It happens in the setting of incessant liver aggravation and is most firmly connected to endless viral hepatitis contamination (hepatitis B or C) or introduction to poisons, for example, liquor or Aflatoxin. Certain ailments, for example, hemochromatosis and alpha 1-antitrypsin lack, particularly increment the danger of treating HCC. Similarly, as with any malignancy, the treatment and forecast of HCC differ contingent upon the specifics of tumor histology, measure, how far growth has spread, and in general wellbeing.

Related Associations:

Track 10: Hepatic Perfusion Techniques

Liver-coordinated high measurements chemotherapy developed from an exceedingly intrusive open surgery to an insignificantly obtrusive strategy known as percutaneous hepatic perfusion (PHP). Amid PHP, three catheters are put percutaneously through standard interventional radiology strategies. The liver is incidentally disconnected from the body's circulatory framework, amid which time a 30-minute implantation of the chemotherapeutic specialist melphalan hydrochloride specifically to the liver happens. The blood is gathered as it leaves the liver for filtration by restrictive channels preceding returning it to the patient.

Related Associations:

Track 11: Liver Imaging Modalities

Imaging is essential for correctly diagnosing biliary tract issue and is basic for distinguishing focal liver wounds (eg, ulcer, tumor). It is constrained in distinguishing and diagnosing diffuse hepatocellular ailment (eg, hepatitis, cirrhosis).

Liver ultrasonography and attractive reverberation (Magnetic Resonance) imaging are progressively utilized for recognizing, describing and evaluating the reaction to the treatment of central and diffuse liver infections. Ultrasonography remains the first-line examination, however, it has as of late increased expanding capacities because of the usage of Dynamic Complexity Improved (DCE) ponders and elastography.

Related Associations:

Track 12: Herbal Medicines and Liver Diseases

Homegrown medications have turned out to be progressively famous and their utilization is across the board. Authorizing controls and pharmacovigilance with respect to homegrown items are as yet inadequate and obvious verification of their viability in liver illnesses is meager. All things considered, various herbals indicate promising movement including silymarin for antifibrotic treatment, Phyllanthus amarus in unending hepatitis B, glycyrrhizin to treat perpetual viral hepatitis, and various homegrown blends from China and Japan that merit testing in proper investigations.

Related Associations:

Track 13: Hepatic-Encephalopathy

The term hepatic encephalopathy alludes to the disorder of neuropsychiatric unsettling influences that may emerge as a complexity of intense, subacute, or interminable hepatocellular disappointment. The disorder is related with expanded entryway fundamental shunting of gut inferred constituents of gateway venous blood, because of their weakened extraction by the coming up short liver and, in many examples, their section through intrahepatic or potentially extrahepatic gateway foundational venous insurance channels.

Related Associations:

Track 14: Hepatitis, Liver Diseases, and Pregnancy

Intense viral hepatitis is the most widely recognized reason for jaundice in pregnancy. The course of most popular contaminations isn't influenced by pregnancy. Jaundice is a trademark highlight of the liver malady. The clinical signs and side effects are unclear between the different types of viral hepatitis, subsequently, the differential determination requires serologic testing for an infection particular conclusion, and the finding is by a biochemical appraisal of liver capacity.

Related Associations:

Track 15: Liver Diseases and Nutritional Management

Nourishment has for quite some time been perceived as a prognostic and helpful determinant in patients with the perpetual liver malady. Exact evaluations of health status are not easily gotten in patients with cirrhosisfundamentally because of the inconsistencies in fluid homeostasis and compartmentalization, protein assimilation and bone exhibiting and remineralization that depict this condition. This makes it difficult to perceive those in threat for debilitated wellbeing and to survey the necessity for, and sufficiency of, nutritious intercession.

Related Associations:

Summary:

Hepatology is the branch of science that consolidates the investigation of a liver, gallbladder, biliary tree, and pancreas and also the administration of their issue. Albeit customarily considered a sub-forte of Gastroenterology, a quick extension has driven in a few nations to specialists practicing exclusively on this zone, who are called hepatologists.

Hepatitis:

Hepatitis is an aggravation of the liver tissue. A few people have no indications though others create yellow staining of the skin and whites of the eyes, poor craving, regurgitating, tiredness, stomach agony, or the runs. Hepatitis might be impermanent (intense) or long haul (incessant) contingent upon whether it goes on for not exactly or over a half year. Intense hepatitis can in some cases resolve without anyone else, advancement to unending hepatitis, or infrequently results in intense liver disappointment. After some time the constant shape may advance to scarring of the liver, liver disappointment, or liver tumor.

Liver Diseases:

The most well-known reason for hepatitis worldwide is infections. Different causes incorporate overwhelming liquor consumption, certain pharmaceuticals, poisons, different contaminations, immune system ailments, and non-alcoholic steatohepatitis (NASH). There are five principal kinds of viral hepatitis: type A, B, C, D, and E. Hepatitis A and E are predominantly spread by debased sustenance and water. Hepatitis B is predominantly sexually transmitted, yet may likewise be passed from mother to infant amid pregnancy or labor. Both hepatitis B and C are normally spread through tainted blood, for example, may happen amid needle sharing by intravenous medication clients. Hepatitis D can just taint individuals officially contaminated with hepatitis B.

Importance & scope:

Hepatology is a branch of science that deals with the prevention, diagnosis, and treatment of liver diseases. A medical professional who practices Hepatology is Hepatologist. Hepatology conveys the effects of clinical and test research in, liver science, especially with trial therapeutics. Topics include incorporating immunobiology, pathogenesis, and treatment of dangerous viral diseases.

Conference Series llc Ltd. welcomes all the Medical Hepatologists, Surgeons, Immunologists, Pathologists, Liver Oncologists, Research scholars, Industrial Professionals and Student Delegates from Biomedical and healthcare sectors to be a part of the esteemed Liver Congress 2019. Advanced Diagnostic and therapeutic equipment along with the novel drugs for the Hepatitis & Liver diseases are an integral part of the Hepatology research, hence it will be an excellent amalgamation of academia and industry as it involves every aspect of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.

Why Japan?

Japan is a leading nation in scientific research, particularly in fields related to the natural sciences and engineering. The country ranks second among the most innovative countries in the Bloomberg Innovation Index. Nearly 700,000 researchers share a US$130 billion research and development budget. The amount spent on research and development relative to the gross domestic product is the third highest in the world. The country is a world leader in fundamental scientific research, having produced twenty-two Nobel laureates in either physics, chemistry or medicine and three Fields Medalists. Meanwhile, Japan already features the world’s second largest markets in pharmaceuticals and medical devices, behind only the United States. This intersection of aging, depopulation, and rich markets creates a laboratory for how the rest of the world will handle the economic and societal changes of aging.

Japanese scientists and engineers have contributed to the advancement of agricultural sciences, electronics, industrial robotics, optics, chemicals, semiconductors, life sciences and various fields of engineering. Japan leads the world in robotics production and use, possessing more than 20% (300,000 of 1.3 million) of the world's industrial robots as of 2013—though its share was historically even higher, representing one-half of all industrial robots worldwide in 2000. Japan boasts the third highest number of scientists, technicians, and engineers per capita in the world with 83 scientists, technicians and engineers per 10,000 employees.

The 7^th World Congress on Hepatitis & Liver Diseases exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 15-16, 2019
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

7^th World Congress on Hepatitis & Liver Diseases March 15-16, 2019 Osaka, Japan

Recommended Global Gastroenterology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Hepatitis Congress 2019

Conference Highlights

To Collaborate Scientific Professionals around the World

Media Partners

Useful Links

Special Issues